Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05221320
Title Trial of Ulixertinib in Combination With Hydroxychloroquine in Patients With Advanced Gastrointestinal (GI) Malignancies
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors BioMed Valley Discoveries, Inc
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Arizona Cancer Center Tucson Arizona 85719 United States Details
University of California San Francisco San Francisco California 94143 United States Details
University of Kansas Cancer Center Fairway Kansas 66205 United States Details
Rogel Cancer Center, University of Michigan Health Ann Arbor Michigan 48109 United States Details
Washington University School of Medicine Saint Louis Missouri 63110 United States Details
Rutgers Cancer Institute of New Jersey New Brunswick New Jersey 08903 United States Details
Mount Sinai New York New York 10029 United States Details
Cleveland Clinic Cleveland Ohio 44195 United States Details
Massey Cancer Center, Virginia Commonwealth University Richmond Virginia 23298 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field